Loading...
You are here:  Home  >  Health  -  Page 5
Latest

Dutch may need to cull millions of hens after insecticide found in eggs

/  07.08.2017  /  Health 

BRUSSELS (Reuters) – Millions of hens may need to be culled in the Netherlands after traces of a potentially harmful insecticide were found in eggs, a Dutch farming group said, ratcheting up the strain on a sector still reeling from a bird flu outbreak.

Read More →
Latest

Anthem to leave Nevada’s Obamacare market

/  07.08.2017  /  Health 

NEW YORK (Reuters) – U.S. health insurer Anthem Inc will no longer offer Obamacare plans in Nevada’s state exchange, the state’s insurance commissioner said on Monday.

Read More →
Latest

Tiny biotech firm offers Big Tobacco model to curb its nicotine habit

/  07.08.2017  /  Health 

LONDON (Reuters) – Investors are betting on a little-known biotech company to supply Big Tobacco with low-nicotine cigarettes, but so far its technology is unproven.

Read More →
Latest

DEA proposes cutting production of some opioid painkillers

/  04.08.2017  /  Health 

(Reuters) – The U.S. Drug Enforcement Administration (DEA) on Friday proposed a 20 percent reduction in the manufacture of certain commonly prescribed opioid painkillers as well as other controlled substances for next year.

Read More →
Latest

Aldi stores in Germany stop selling eggs amid Dutch food safety scare

/  04.08.2017  /  Health 

FRANKFURT (Reuters) – Discount supermarket chain Aldi, which has more than 4,000 stores in Germany, said on Friday it was pulling all eggs from store shelves in the country as a precaution after a scare over the possible contamination of eggs from the Netherlands.

Read More →
Latest

Wal-Mart, Walgreens, CVS turn up the heat on generic drugmaker deals

/  04.08.2017  /  Health 

(Reuters) – The largest U.S. retail pharmacies, including Wal-Mart Stores Inc and Walgreens Boots Alliance Inc, are wielding more leverage when buying generic drugs, accelerating a decline in prices likely to affect drug companies for some time, industry experts said on Thursday.

Read More →
Latest

Shire may spin off hyperactivity drugs, raises forecasts

/  03.08.2017  /  Health 

LONDON (Reuters) – Shire, the London-listed pharmaceutical firm built up by acquisitions, said it might spin off its hyperactivity drugs business into a separate company and focus solely on rare disease treatments.

Read More →
Latest

U.S. governors urge Trump to make insurance payments

/  03.08.2017  /  Health 

WASHINGTON (Reuters) – Democratic and Republican U.S. governors on Wednesday urged the Trump administration, as well as Congress, to continue funding payments to health insurance companies that make Obamacare plans affordable, calling it critical to stabilizing the insurance marketplace.

Read More →
Latest

FDA panel votes against approval of J&J arthritis drug

/  02.08.2017  /  Health 

(Reuters) – The benefits of Johnson & Johnson’s experimental rheumatoid arthritis drug sirukumab do not outweigh the risks and it should not be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday.

Read More →
Latest

UK finds Roche bladder cancer drug too costly for routine use

/  02.08.2017  /  Health 

LONDON (Reuters) – Britain’s healthcare cost-effectiveness agency NICE has decided Roche’s new immunotherapy drug Tecentriq is too expensive to justify its routine use to treat bladder cancer, but still hopes it can be used in certain circumstances.

Read More →